APA

Cosgrove C. M., Cohn D. E., Hampel H., Frankel W. L., Jones D., McElroy J. P., Suarez A. A., Zhao W., Chen W., Salani R., Copeland L. J., O'Malley D. M., Fowler J. M., Yilmaz A., Chassen A. S., Pearlman R., Goodfellow P. J. & Backes F. J. (20170919). Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival. : Gynecologic oncology.

Chicago

Cosgrove Casey M, Cohn David E, Hampel Heather, Frankel Wendy L, Jones Dan, McElroy Joseph P, Suarez Adrian A, Zhao Weiqiang, Chen Wei, Salani Ritu, Copeland Larry J, O'Malley David M, Fowler Jeffrey M, Yilmaz Ahmet, Chassen Alexis S, Pearlman Rachel, Goodfellow Paul J and Backes Floor J. 20170919. Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival. : Gynecologic oncology.

Harvard

Cosgrove C. M., Cohn D. E., Hampel H., Frankel W. L., Jones D., McElroy J. P., Suarez A. A., Zhao W., Chen W., Salani R., Copeland L. J., O'Malley D. M., Fowler J. M., Yilmaz A., Chassen A. S., Pearlman R., Goodfellow P. J. and Backes F. J. (20170919). Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival. : Gynecologic oncology.

MLA

Cosgrove Casey M, Cohn David E, Hampel Heather, Frankel Wendy L, Jones Dan, McElroy Joseph P, Suarez Adrian A, Zhao Weiqiang, Chen Wei, Salani Ritu, Copeland Larry J, O'Malley David M, Fowler Jeffrey M, Yilmaz Ahmet, Chassen Alexis S, Pearlman Rachel, Goodfellow Paul J and Backes Floor J. Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival. : Gynecologic oncology. 20170919.